Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Common Equity (2022 - 2025)

Historic Common Equity for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $2.3 million.

  • Neuraxis' Common Equity rose 22737.05% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 22737.05%. This contributed to the annual value of $2.1 million for FY2024, which is 24735.52% up from last year.
  • Latest data reveals that Neuraxis reported Common Equity of $2.3 million as of Q3 2025, which was up 22737.05% from $4.3 million recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' Common Equity peaked at $4.3 million during Q2 2025, and registered a low of -$10.0 million during Q2 2023.
  • Moreover, its 4-year median value for Common Equity was -$1.4 million (2023), whereas its average is -$1.8 million.
  • The largest annual percentage gain for Neuraxis' Common Equity in the last 5 years was 24735.52% (2024), contrasted with its biggest fall of 6906.55% (2024).
  • Neuraxis' Common Equity (Quarter) stood at -$5.6 million in 2022, then surged by 74.82% to -$1.4 million in 2023, then soared by 247.36% to $2.1 million in 2024, then increased by 10.5% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $4.3 million for Q2 2025, and $258479.0 during Q1 2025.